Earnings History Data for Nuvectis Pharma, Inc. (NVCT) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Nuvectis Pharma, Inc.
Nuvectis Pharma Inc. is a biopharmaceutical company. It focused on the development of innovative precision medicines for serious conditions of unmet medical need in oncology. Nuvectis Pharma Inc. is based in Fort Lee, NJ.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05-03-2024 | ?? | NVCT | Nuvectis Pharma, Inc. | 185.39 | -0.41 | -0.40 | -0.48 | Nuvectis Pharma GAAP EPS of -$1.43 beats by $0.16 [3/6/2024 1:07 PM] |
10.18 | 0.34 (3.46%) |
9.84 | 0.0 (0.00%) |
6.20 - 18.65 | 99,404 | 160,000 | 571 | ||
| 08-11-2023 | PM | NVCT | Nuvectis Pharma | 159.00 | -0.37 | -0.38 | 0.00 | Nuvectis Pharma GAAP EPS of -$0.37 [11/8/2023 9:04 AM] |
8.24 | -0.70 (-7.83%) |
0.0 | 0.0 (0.00%) |
6.70 - 18.65 | 25,241 | 50,000 | 0 | ||
| 09-08-2023 | PM | NVCT | Nuvectis Pharma | 233.00 | -0.38 | -0.34 | 0.00 | 15.00 | 0.20 (1.35%) |
15.15 | 0.35 (2.36%) |
6.21 - 18.65 | 43,308 | 40,000 | 235 | |||
|
|
||||||||||||||||||
| 07-03-2023 | PM | 8:00 AM ET (Mar 7) |
NVCT | Nuvectis Pharma | 175.00 | -0.48 | -0.36 | 0.00 | 11.28 | -0.62 (-5.21%) |
0.0 | 0.0 (0.00%) |
6.02 - 20.92 | 13,508 | 10,000 | 0 | ||
|
|
||||||||||||||||||
| 08-11-2022 | PM | NVCT | Nuvectis Pharma | 102.00 | -0.42 | -0.27 | 0.00 | Nuvectis Pharma GAAP EPS of -$0.42 misses by $0.15 [11/8/2022 9:24 AM] |
7.11 | 0.06 (0.85%) |
0.0 | 0.0 (0.00%) |
3.08 - 20.92 | 1,959 | 0 | 0 | ||
| 05-08-2022 | PM | NVCT | Nuvectis Pharma | 108.00 | -0.28 | -0.24 | 0.00 | Nuvectis Pharma GAAP EPS of -$0.28 misses by $0.04 [8/5/2022 8:58 AM] |
8.55 | -0.06 (-0.70%) |
0.0 | 0.0 (0.00%) |
3.08 - 20.92 | 13,456 | 20,000 | 0 | ||
| 10-05-2022 | PM | NVCT | Nuvectis Pharma, Inc. | 231.00 | -0.32 | -0.23 | 0.00 | Nuvectis Pharma GAAP EPS of -$0.32 misses by $0.09 [5/10/2022 8:58 AM] |
13.85 | -1.21 (-8.03%) |
14.13 | -0.93 (-6.18%) |
3.08 - 19.97 | 58,503 | 606,031 | 476 | ||